Optimization of a Glucagon-Like Peptide 1 Receptor Antagonist Antibody for Treatment of Hyperinsulinism

Researchers designed a combinatorial variant antibody library to optimize the activity of TB-001-003 against glucagon-like peptide 1 receptor (GLP-1R), and performed phage-display on cells overexpressing GLP-1R.